These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37969284)

  • 1. Changes in T lymphocyte subsets predict the efficacy of atezolizumab in advanced non-small cell lung cancer: a retrospective study.
    Wang Y; Zhu J; Zhou N; Wang Y; Zhang X
    J Thorac Dis; 2023 Oct; 15(10):5669-5679. PubMed ID: 37969284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of Pembrolizumab on T Lymphocyte Subsets in Patients with Advanced 
Non-small Cell Lung Cancer and Its Therapeutic Effect].
    Wang Y; Wang Y; Jiang M; Zhao Y; Zhang X
    Zhongguo Fei Ai Za Zhi; 2021 Mar; 24(3):182-187. PubMed ID: 33819968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pembrolizumab on T lymphocyte subsets in patients with advanced oral cancer and its therapeutic effect.
    Feng L; Li TK; Yin K; Zhang SX; Chen Z; Bao Y
    Medicine (Baltimore); 2022 Sep; 101(36):e30534. PubMed ID: 36086675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of lymphocyte subsets with efficacy and prognosis of immune checkpoint inhibitor therapy in advanced non-small cell lung carcinoma: a retrospective study.
    Yan Y; Wang X; Liu C; Jia J
    BMC Pulm Med; 2022 Apr; 22(1):166. PubMed ID: 35484541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy.
    Wu SP; Liao RQ; Tu HY; Wang WJ; Dong ZY; Huang SM; Guo WB; Gou LY; Sun HW; Zhang Q; Xie Z; Yan LX; Su J; Yang JJ; Zhong WZ; Zhang XC; Wu YL
    J Thorac Oncol; 2018 Apr; 13(4):521-532. PubMed ID: 29269008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of PD-1 and PD-L1 in the peripheral blood of advanced non-small-cell lung cancer patients and its implications].
    Xing YF; Pan X; Qian B; Shi MH
    Zhonghua Yi Xue Za Zhi; 2019 Jan; 99(2):111-114. PubMed ID: 30669748
    [No Abstract]   [Full Text] [Related]  

  • 7. Aberrant Alteration of Circulating Lymphocyte Subsets in Small Cell Lung Cancer Patients Treated with Radiotherapy.
    Li H; Yu H; Lan S; Zhao D; Liu Y; Cheng Y
    Technol Cancer Res Treat; 2021; 20():15330338211039948. PubMed ID: 34851203
    [No Abstract]   [Full Text] [Related]  

  • 8. Associations between peripheral blood lymphocyte subsets and clinical outcomes in patients with lung cancer treated with immune checkpoint inhibitor.
    Li P; Qin P; Fu X; Zhang G; Yan X; Zhang M; Zhang X; Yang J; Wang H; Ma Z
    Ann Palliat Med; 2021 Mar; 10(3):3039-3049. PubMed ID: 33849094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity of lymphocyte subsets in predicting immune checkpoint inhibitor treatment response in advanced lung cancer: an analysis across different pathological types, therapeutic drugs, and age groups.
    Miao C; Chen Y; Zhang H; Zhao W; Wang C; Ma Z; Zhu S; Hu X
    Transl Lung Cancer Res; 2024 Jun; 13(6):1264-1276. PubMed ID: 38973958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential predictive value of circulating immune cell ratio and tumor marker in atezolizumab treated advanced non-small cell lung cancer patients.
    Zhuo M; Chen H; Zhang T; Yang X; Zhong J; Wang Y; An T; Wu M; Wang Z; Huang J; Zhao J
    Cancer Biomark; 2018; 22(3):467-476. PubMed ID: 29758930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of lymphocyte subsets with the efficacy and prognosis of PD‑1 inhibitor therapy in advanced gastric cancer: results from a monocentric retrospective study.
    Wang X; Liu X; Dai H; Jia J
    BMC Gastroenterol; 2024 Mar; 24(1):113. PubMed ID: 38491354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deep Sequencing of T-Cell Receptors for Monitoring Peripheral CD8
    Sheng J; Wang H; Liu X; Deng Y; Yu Y; Xu P; Shou J; Pan H; Li H; Zhou X; Han W; Sun T; Pan H; Fang Y
    Front Mol Biosci; 2021; 8():679130. PubMed ID: 34307450
    [No Abstract]   [Full Text] [Related]  

  • 13. Association Between Response to Nivolumab Treatment and Peripheral Blood Lymphocyte Subsets in Patients With Non-small Cell Lung Cancer.
    Ottonello S; Genova C; Cossu I; Fontana V; Rijavec E; Rossi G; Biello F; Dal Bello MG; Tagliamento M; Alama A; Coco S; Boccardo S; Vanni I; Ferlazzo G; Moretta L; Grossi F; Mingari MC; Carrega P; Pietra G
    Front Immunol; 2020; 11():125. PubMed ID: 32117275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of dendritic cells on immune function regulated by programmed cell death-1/programmed cell death-ligand 1 in sepsis].
    Wang Z; Xie Z; Zhao Y; Bu T; Yu A; Wang S
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Sep; 33(9):1032-1039. PubMed ID: 34839857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T lymphocyte subsets and PD-1 expression on lymphocytes in peripheral blood of patients with non-small cell lung cancer.
    Chen T; Chen H; Lu W; Yao Y
    Medicine (Baltimore); 2022 Oct; 101(42):e31307. PubMed ID: 36281084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The peripheral CD4
    Zhuang W; Wang M; Jiang L; Su Z; Lin S
    Transl Cancer Res; 2024 Aug; 13(8):4052-4061. PubMed ID: 39262495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-index comprehensive evaluation of the efficacy and response mechanism of immunotherapy in non-small cell lung cancer.
    Fan J; Zhang T
    Clin Transl Oncol; 2024 Dec; 26(12):3124-3130. PubMed ID: 38822977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical significance of T lymphocyte subset changes after first line chemotherapy in peripheral blood from patients with advanced stage adenocarcinoma cell lung cancer].
    Yan X; Zhao X; Jiao S; Sun S; Wu L; Wu Z
    Zhongguo Fei Ai Za Zhi; 2012 Mar; 15(3):164-71. PubMed ID: 22429580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics and clustering analysis of peripheral blood lymphocyte subsets in children with systemic lupus erythematosus complicated with clinical infection.
    Deng Y; Ou YY; Mo CJ; Huang L; Qin X
    Clin Rheumatol; 2023 Dec; 42(12):3299-3309. PubMed ID: 37537315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A nomogram model based on peripheral blood lymphocyte subsets to assess the prognosis of non-small cell lung cancer patients treated with immune checkpoint inhibitors.
    Xu X; Wang D; Chen W; Li N; Suwinski R; Rossi A; Rosell R; Zhong J; Fan Y
    Transl Lung Cancer Res; 2021 Dec; 10(12):4511-4525. PubMed ID: 35070757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.